Compounds > taxifolin

taxifolin and Breast Neoplasms

taxifolin has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Berti, F; Colombo, G; Grazioso, G; Magistrato, A; Martini, S; Pavlin, M; Pennati, M; Sgrignani, J; Spinello, A; Zaffaroni, N1
Chittiboyina, AG; Cleary, J; Deshpande, R; Liu, Y; Miller, LD; Mo, YY; Sharma, S; Tyagi, A; Wang, Y; Watabe, K; Wu, K; Wu, SY; Xing, F; Yalamanchili, C; Zhao, D1
Gong, X; Hu, L; Jiang, R; Kuang, G; Li, H; Li, J; Wan, J; Zhou, T1
Bast, A; Boven, E; Grimbergen, JA; Kramer, K; Kuiper, K; van Acker, SA; van den Berg, DJ; van der Vijgh, WJ1

Other Studies

4 other study(ies) available for taxifolin and Breast Neoplasms

ArticleYear
Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
    European journal of medicinal chemistry, 2019, Apr-15, Volume: 168

    Topics: Allosteric Regulation; Antineoplastic Agents; Aromatase; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship

2019
Epigenetic and Posttranscriptional Modulation of SOS1 Can Promote Breast Cancer Metastasis through Obesity-Activated c-Met Signaling in African-American Women.
    Cancer research, 2021, 06-01, Volume: 81, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biomarkers, Tumor; Black or African American; Breast Neoplasms; Cell Proliferation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; GRB2 Adaptor Protein; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Obesity; Prognosis; Proto-Oncogene Proteins c-met; Quercetin; SOS1 Protein; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021
Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling.
    Life sciences, 2019, Sep-01, Volume: 232

    Topics: Animals; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Quercetin; Signal Transduction; Xenograft Model Antitumor Assays

2019
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss

1997